In particular, CIN-related pain is sustained by a spinal VEGF-A release from astrocytes and can be counteracted by local or systemic administration of the anti-VEGFR-1 D16F7, a mAb also endowed with anti-angiogenic and antitumor activity. The gene discussed is FLT1; the disease is cervical squamous intraepithelial neoplasia.